News & Articles

Logix Smart™ COVID-19 test CE marked & available in Europe four weeks after project initiation

Positive in vivo efficacy and pharmacokinetic data shows AVA04-VbP drug conjugate out-performed Bavencio immunotherapy

The molecule points the way toward treating viruses that cross from animals to humans

The antibody is being trialed for use in the treatment of B cell Acute Lymphoblastic Leukemia

PWC-Colorcon-TruTag technology coalition prove out the mass digitalization of pharma pills

World’s first portable, low-cost MRI system is a new tool for clinical diagnosis and patient monitoring

Harvard, MIT, and various teaching hospitals team up with industry partners to launch new center for regenerative therapies

Clinical trial will evaluate the safety and immunogenicity of Entervax™

Distinguished speaker Dr. Bruce Levine addresses some of the current healthcare challenges that impact the development of new therapies

Proximity will facilitate local and international sponsor access to Kayentis’ eCOA services for mid- to later-stage clinical trials

Zelluna Immunotherapy presented data on its lead compound ZI-H04 at the Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Lead allosteric PLK1 inhibitor to progress through preclinical and IND enabling studies

Thermo Fisher Scientific's forum focuses on strategies to expedite biotherapeutic development and commercialization

New collaboration to focus on developing potent Affimer-drug conjugates

SelectScience is heading to Chicago, USA, to interview scientists at the forefront of neuroscience research and report on the latest techniques and technologies advancing the field

AstraZeneca BioPharmaceuticals R&D has invested in a LyoConstellationTM S10 freeze dryer intended to help drive research and development of small scale GMP production.

Study done at the University of Cambridge suggests a way to predict prognosis and most effective treatment in cancer

Roche's Tecentriq improves overall survival as a first-line monotherapy in certain people with advanced non-small cell lung cancer

Women with a rare type of ovarian cancer could benefit from a drug that quadruples the likelihood of response compared with standard therapies

Tell us which new products made the most difference to your lab work and you’ll have the chance to win one of four $500 Amazon gift cards

Study aims to develop a rapid point-of-care diagnostic based on multiple biomarkers to detect emergent sepsis

Abbott's new technology is poised to be the first point-of-care blood test for assessing concussions, providing doctors results in 15 minutes

Following last year’s success, we’re hosting our second annual event dedicated to celebrating our Seals of Quality program